Page 1,355«..1020..1,3541,3551,3561,357..1,3601,370..»

Department of Microbiology and Molecular Genetics

Posted: October 7, 2018 at 4:47 pm

I welcome you to the Department of Microbiology and Molecular Genetics. Our department is uniquely positioned in two colleges at the University of Vermont: the Robert Larner, M.D., College of Medicine (LCOM) and the College of Agriculture and Life Sciences (CALS). At CALS, MMG hosts two outstanding undergraduate majors, Microbiology and Molecular Genetics. Our highly-recognized faculty educators work closely with our undergraduate students throughout their years at UVM as they become excellent scientists and innovative, critical thinkers. At LCOM, our faculty are closely engaged with teaching and training medical students, as well as graduate students, in our Cellular, Molecular and Biomedical Sciences (CMB) Ph.D. program and Medical Masters program.

Our faculty are highly focused on research, which spans from basic-science inquiry in the fields of Microbiology; Cell, Molecular and Structural biology; to applied and translational research in human immunology, vaccine, and bioinformatics and genetics. MMG hosts a nationally recognized team exploring the mechanisms of DNA Repair, research that is critically important to human diseases, including cancer. The recent addition of the UVM Vaccine Testing Center team to MMG complements our research portfolio by adding significant new depth in clinical and translational human immunology and vaccinology, as well as U.S.-based and international clinical trials, all with a focus on preventing and controlling infectious diseases of global importance.

Thank you for your interest in MMG. We look forward to hearing from you!

Beth Kirkpatrick, M.D.Professor and Chair, Department of Microbiology and Molecular GeneticsDirector, Vaccine Testing Center

See the rest here:
Department of Microbiology and Molecular Genetics

Posted in Molecular Genetics | Comments Off on Department of Microbiology and Molecular Genetics

How does gene therapy work? – Scientific American

Posted: October 7, 2018 at 4:46 pm

Gene therapy is the addition of new genes to a patient's cells to replace missing or malfunctioning genes. Researchers typically do this using a virus to carry the genetic cargo into cells, because thats what viruses evolved to do with their own genetic material.

The treatment, which was first tested in humans in 1990, can be performed inside or outside of the body. When its done inside the body, doctors may inject the virus carrying the gene in question directly into the part of the body that has defective cells. This is useful when only certain populations of cells need to be fixed. For example, researchers are using it to try to treat Parkinson's disease, because only part of the brain must be targeted. This approach is also being used to treat eye diseases and hemophilia, an inherited disease that leads to a high risk for excess bleeding, even from minor cuts.

Early in-the-body gene therapies used a virus called adenovirusthe virus behind the common coldbut the agent can cause an immune response from the body, putting a patient at risk of further illness. Today, researchers use a virus called adeno-associated virus, which is not known to cause any disease in humans. In nature, this agent needs to hitch a ride with an adenovirus, because it lacks the genes required to spread itself on its own. To produce an adeno-associated virus that can carry a therapeutic gene and live on its own, researchers add innocuous DNA from adenovirus during preparation.

In-the-body gene therapies often take advantage of the natural tendency of viruses to infect certain organs. Adeno-associated virus, for example, goes straight for the liver when it is injected into the bloodstream. Because blood-clotting factors can be added to the blood in the liver, this virus is used in gene therapies to treat hemophilia.

In out-of-the-body gene therapy, researchers take blood or bone marrow from a patient and separate out immature cells. They then add a gene to those cells and inject them into the bloodstream of the patient; the cells travel to the bone marrow, mature and multiply rapidly, eventually replacing all of the defective cells. Doctors are working on the ability to do out-of-the-body gene therapy to replace all of a patient's bone marrow or the entire blood system, as would be useful in sickle-cell anemiain which red blood cells are shaped like crescents, causing them to block the flow of blood.

Out-of-the-body gene therapy has already been used to treat severe combined immunodeficiencyalso referred to as SCID or boy-in-the-bubble syndromewhere patients are unable to fight infection and die in childhood. In this type of gene therapy, scientists use retroviruses, of which HIV is an example. These agents are extremely good at inserting their genes into the DNA of host cells. More than 30 patients have been treated for SCID, and more than 90 percent of those children have been cured of their disorderan improvement over the 50 percent chance of recovery offered by bone marrow transplants.

A risk involved with retroviruses is that they may stitch their gene anywhere into DNA, disrupting other genes and causing leukemia. Unfortunately, five of the 30 children treated for SCID have experienced this complication; four of those five, however, have beaten the cancer. Researchers are now designing delivery systems that will carry a much lower risk of causing this condition.

Although there are currently no gene therapy products on the market in the U.S., recent studies in both Parkinson's disease and Leber congenital amaurosis, a rare form of blindness, have returned very promising results. If these results are borne out, there could be literally hundreds of diseases treated with this approach.

See the article here:
How does gene therapy work? - Scientific American

Posted in Gene therapy | Comments Off on How does gene therapy work? – Scientific American

Regenerative Medicine Conferences | Tissue Science …

Posted: October 6, 2018 at 11:42 pm

About the Conference

Conference Series llc LTDinvites all participants to attend 11thInternational Conference on Tissue Engineering & Regenerative Medicinewhich is going to be held during October 18-20, 2018 at Rome, Italy mainly focuses on two key topics viz.Tissue EngineeringandRegenerative Medicine with basic theme Redefining Health Care through Regenerative Medicine.

Regenerative Medicine -2018 provides an ideal environment to discuss on recent strategies in tissue engineering and regenerative medicine for disease remediation and tissue repair.

11thInternational Conference on Tissue Engineering & Regenerative Medicinemainlyfocuses on Stem Cell Research and Tissue Engineering.Stem cell Researchincludes stem cell treatment for various disease and conditions includeDiabetes, Rheumatoid arthritis, Parkinson's disease, Alzheimer's disease, Osteoarthritis, Stroke and traumatic brain injury repair, Learning disability due to congenital disorder, Spinal cord injury repair,Heart infarction, Anti-cancer treatments, Baldness reversal, Replace missing teeth, Repair hearing, Restore vision and repair damage to the cornea, Amyotrophic lateral sclerosis, Crohn's disease, Wound healing, Male infertility due to absence of spermatogonial stem cells etc.,Tissue Engineeringincludes Bone tissue engineering, soft tissues, tissue imaging, tissue implant, cartilage and skin defects are a special focus along with applying basic science and engineering principles from diverse areas towards solving clinically relevant biomedical problems.

Conference Series llc LTDis a Worlds leading Event Organizer that organizes 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Targeted Audience:

Major Sessions:

Scaffolds Cord Blood & Regenerative Medicine Bone and Cartilage Tissue Engineering Stem Cells-Tools to Battle Cancer Novel Approaches in Guided Tissue Regeneration Clinical Medicine Clinical Trials with Stem Cells Biomaterials and Bioengineering Tissue Biomarkers Regeneration and Therapeutics Rejuvenation Immunotherapy Stem Cell Treatment for Diabetes Applications of Tissue Engineering and Regenerative Medicine Bioreactors in Tissue Engineering Biochips and Tissue Chips Cancer Stem Cells Tissue Regeneration Advances in Stem Cell Materials and Designs for Tissue Engineering Tissue Engineering and 3D Printing Whole Organ Engineering and Approaches Stem Cell Engineering (SCE)

Scaffolds

Scaffoldsare one of the three most important elements constituting the basic concept ofregenerative medicine, and are included in the core technology of regenerative medicine. Every day thousands of surgical procedures are performed to replace or repair tissue that has been damaged through disease or trauma. The developing field oftissue engineering(TE) aims to regenerate damagedtissuesby combining cells from the body with highly porous scaffoldbiomaterials, which act as templates fortissue regeneration, to guide the growth of new tissue. Scaffolds has a prominent role in tissue regeneration the designs, fabrication, 3D models, surface ligands andmolecular architecture, nanoparticle-cell interactions and porous of the scaffolds are been used in the field in attempts to regenerate different tissues and organs in the body. The worldstem cell marketwas approximately 2.715 billion dollars in 2010, and with a growth rate of 16.8% annually, a market of 6.877 billion dollars will be formed in 2016. From 2017, the expected annual growth rate is 10.6%, which would expand the market to 11.38 billion dollars by 2021.

RelatedRegenerative Medicine Conferences|Stem Cell Conferences|Stem Cell Congress|Tissue Science Conferences|EuropeConferences

ISSCR 2018 Annual Meeting, June 20-23, 2018 Melbourne, Australia;Generating Diverse Cells and Networks in the Nervous System, Gordon Conference, July 29-August 3, 2018 Newport, RI, USA;6thCambridge International Stem Cell Symposium, September 19-21, 2018 Cambridge, UK;Modeling Cell-Cell Interactions Governing Tissue Repair & Disease, Gordon Conference, August 19-24, 2018 Waterville Valley, NH, USA;27thInternational Conference On Oncology Research & Cancer Stem CellsMay 10-12, 2018 Frankfurt, Germany;10thAnnual Conference On Stem Cell And Regenerative MedicineAugust 13-14, 2018 London, UK;7thInternational Conference And Exhibition On Cell And Gene TherapyMarch 15-17, 2018 London, UK.

Related Associations and Societies:

Europe:EuroStemCell (European Consortium for Stem Cell Research);German Stem Cell Network (GSCN);German Society for Stem Cell Research (GSZ);Stem Cell Network North Rhine-Westphalia (NRW);Norwegian Center for Stem Cell Research (NCSCR);

USA:California Institute for Regenerative Medicine (CIRM);New York Stem Cell Foundation (NYSCF);Tissue Engineering International & Regenerative Medicine Society (TERMIS);International Society for Stem Cell Research (ISSCR);

Asia:

The New South Wales Stem Cell Network;Korean Society for Stem Cell Research;Japanese Society for Regenerative Medicine;Taiwan Society for Stem Cell Research;Stem Cell Society Singapore (SCSS);

Tissue Regeneration

In the field of biology, regeneration is the progression of renewal, regeneration, and growth that makes it possible for genomes, cells, organ regeneration to natural changes or events that cause damage or disturbance. This study is carried out as craniofacial tissue engineering, in-situ tissue regeneration, adipose-derived stem cells for regenerative medicine which is also a breakthrough in cell culture technology. The study is not stopped with the regeneration of tissue where it is further carried out in relation with cell signalling, morphogenetic proteins. Most of the neurological disorders occurred accidental having a scope of recovery by replacement or repair of intervertebral discs repair, spinal fusion, and many more advancements. The global market for tissue engineering and regeneration products such as scaffolds, tissue implants, biomimetic materials reached $55.9 billion in 2010 and it is expected to reach $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%. It grows to $135 billion by 2024.

RelatedRegenerative Medicine Conferences|Stem Cell Conferences|Stem Cell Congress|Tissue Science Conferences|EuropeConferences

ISSCR 2018 Annual Meeting, June 20-23, 2018 Melbourne, Australia;Generating Diverse Cells and Networks in the Nervous System, Gordon Conference, July 29-August 3, 2018 Newport, RI, USA;6thCambridge International Stem Cell Symposium, September 19-21, 2018 Cambridge, UK;Modeling Cell-Cell Interactions Governing Tissue Repair & Disease, Gordon Conference, August 19-24, 2018 Waterville Valley, NH, USA;27thInternational Conference On Oncology Research & Cancer Stem CellsMay 10-12, 2018 Frankfurt, Germany;10thAnnual Conference On Stem Cell And Regenerative MedicineAugust 13-14, 2018 London, UK;7thInternational Conference And Exhibition On Cell And Gene TherapyMarch 15-17, 2018 London, UK.

Related Associations and Societies:

Europe:EuroStemCell (European Consortium for Stem Cell Research);German Stem Cell Network (GSCN);German Society for Stem Cell Research (GSZ);Stem Cell Network North Rhine-Westphalia (NRW);Norwegian Center for Stem Cell Research (NCSCR);

USA:California Institute for Regenerative Medicine (CIRM);New York Stem Cell Foundation (NYSCF);Tissue Engineering International & Regenerative Medicine Society (TERMIS);International Society for Stem Cell Research (ISSCR);

Asia:

The New South Wales Stem Cell Network;Korean Society for Stem Cell Research;Japanese Society for Regenerative Medicine;Taiwan Society for Stem Cell Research;Stem Cell Society Singapore (SCSS);

Advances in Stem Cell

Since the beginning of there has been a effective research in the field of stem cell biology, recent advances in the field of stem cell research mainly focused in the translation of scientific insights into new therapies. It represents a new strategy for organ and tissue repair in several pathologies. Additional treatment strategies are urgently needed due to donor organ shortage that costs many lives every year and results in lifelong immunosuppression. Stem cells are characterized by the ability to renew themselves and differentiating into a various range of specialized cell types. Stem cells have potential to treat various diseases, genetic bone marrow disorders and the treatment of malignant. Being all other stem cell applications highly experimental, Moreover, there is a growing body of evidence showing that administration of stem cells leads to the successful regeneration of tissues or organ.

RelatedRegenerative Medicine Conferences|Stem Cell Conferences|Stem Cell Congress|Tissue Science Conferences|EuropeConferences

10thWorld Congress And Expo On Cell & Stem Cell ResearchMarch 19-21, 2018 New York, USA;Generating Diverse Cells and Networks in the Nervous System, Gordon Conference, July 29-August 3, 2018 Newport, RI, USA;11thWorld Congress On Cell & Tissue ScienceMay 14-15, 2018 Tokyo, Japan;11thInternational Conference And Exhibition On Metabolomics & Systems BiologyMay 16-18, 2018 Tokyo, Japan;World Congress On Cell And Structural BiologyMay 28-29, 2018 Osaka, Japan;13thInternational Conference On Metabolomics And Systems BiologyJune 11-12, 2018 London, UK;10thGlobal Summit On Immunology And Cell BiologyMay 28-29, 2018 Osaka, Japan;World Congress On Stem Cell Biology And BiobankingAugust 20-21, 2018 Tokyo, Japan;2nd Annual Summit On Cell MetabolismSeptember 19 - 20, 2018 Philadelphia, USA.

Related Associations and Societies:

Europe:German Stem Cell Network (GSCN);German Society for Stem Cell Research (GSZ);Stem Cell Network North Rhine-Westphalia (NRW);ScanBalt Stem Cell Research Network;EuroStemCell (European Consortium for Stem Cell Research);Norwegian Center for Stem Cell Research (NCSCR);British Association of Tissue Banks.

USA:Regenerative Medicine Foundation;American association of tissue banks;California Institute for Regenerative Medicine (CIRM);New York Stem Cell Foundation (NYSCF);Tissue Engineering International & Regenerative Medicine Society (TERMIS).

Asia:

Asia Pacific Association of Surgical Tissue Banking;Japanese Society for Regenerative Medicine;Taiwan Society for Stem Cell Research;The New South Wales Stem Cell Network;Korean Society for Stem Cell Research.

Materials and Designs for Tissue Engineering

Tissue engineering of musculoskeletal tissues, particularly bone and cartilage, is a rapidly advancing field. In bone, technology has centered on bone graft substitute materials and the development of biodegradable scaffolds. Recently, tissue engineering strategies have included cell and gene therapy. The availability of growth factors and the expanding knowledge base concerning the bone regeneration with modern techniques like recombinant signalling molecules, solid free form fabrication of scaffolds, synthetic cartilage, Electrochemical deposition, spinal fusion and ossification are new generated techniques for tissue-engineering applications. The worldwide market for bone and cartilage repairs strategies is estimated about $300 million. During the last 10/15 years, the scientific community witnessed and reported the appearance of several sources of stem cells with both osteo and chondrogenic potential.

RelatedRegenerative Medicine Conferences|Stem Cell Conferences|Stem Cell Congress|Tissue Science Conferences|EuropeConferences

2nd Annual Summit On Cell Signaling And Cancer TherapySeptember 19 - 20, 2018 Philadelphia, USA;2ndAnnual Summit On Cell Therapy And Regenerative MedicineOctober 03-04, 2018 Atlanta, USA;Cellular Therapies2018 San Francisco, USA;4thInternational Conference On Central Nervous System Disorders & TherapeuticsNovember 12-14, 2018 Edinburgh, Scotland;10thGlobal Summit On Immunology And Cell BiologyMay 28-29, 2018 Osaka, Japan;World Congress On Stem Cell Biology And BiobankingAugust 20-21, 2018 Tokyo, Japan;2nd Annual Summit On Cell MetabolismSeptember 19 - 20, 2018 Philadelphia, USA.

Related Associations and Societies:

Europe:European Association of Tissue Banks;Norwegian Center for Stem Cell Research (NCSCR);ScanBalt Stem Cell Research Network;Danish Stem Cell Society (DASCS);Stem Cell Network North Rhine-Westphalia.

USA:American association of tissue banks;International Society for Stem Cell Research (ISSCR);Adult Stem Cell Research Network (ASCR);California Institute for Regenerative Medicine (CIRM);New York Stem Cell Foundation (NYSCF)

Asia:

Korean Society for Stem Cell Research;Stem Cell Society Singapore (SCSS);Japanese Society for Regenerative Medicine;Australian Society for Stem Cell Research (ASSCR);Taiwan Society for Stem Cell Research;

Tissue Engineering and 3D Printing

Aims to fabricate of multifunctional scaffolds that meet the mechanical, structural, and nutritional requirements based on optimized models. Computer-aided three-dimensional (3D) printing technology is driving major innovations in many areas, such as engineering, manufacturing, art, education and medicine. It is being applied to regenerative medicine to address the need for tissues and organs suitable for transplantation. Recently, it has shown a great promise in tissue fabrication with structural control from micro- to macro-scale by using a layer-by-layer approach. It involves additional complexities, such as choice of materials, cell types, growth and differentiation factors, and technical challenges related to the sensitivities of living cells and the construction of tissues. It has been already used for the generation and transplantation of several tissues, including multi-layered skin, bone, vascular grafts, tracheal splints, heart tissue and cartilaginous structures. Other applications involve developing the high-throughput 3D-bioprinted tissue models for analysis, drug discovery, and pharmacological medicine. This track will cover several approaches that have advanced the field of 3D technology through novel fabrication methods of tissue engineering constructs.

RelatedRegenerative Medicine Conferences|Stem Cell Conferences|Stem Cell Congress|Tissue Science Conferences|EuropeConferences

11thWorld Congress On Cell & Tissue ScienceMay 14-15, 2018 Tokyo, Japan;11thInternational Conference And Exhibition On Metabolomics & Systems BiologyMay 16-18, 2018 Tokyo, Japan;World Congress On Cell And Structural BiologyMay 28-29, 2018 Osaka, Japan;13thInternational Conference On Metabolomics And Systems BiologyJune 11-12, 2018 London, UK;10thGlobal Summit On Immunology And Cell BiologyMay 28-29, 2018 Osaka, Japan;6thCambridge International Stem Cell Symposium, September 19-21, 2018 Cambridge, UK

Related Associations and Societies:

Europe:The Swiss Stem Cell Network;Danish Stem Cell Society (DASCS);Stem Cell Network North Rhine-Westphalia.EuroStemCell (European Consortium for Stem Cell Research);German Stem Cell Network (GSCN);ScanBalt Stem Cell Research Network;European Calcified Tissue Society;European Association of Tissue Banks.

USA:Adult Stem Cell Research Network (ASCR);International Society for Stem Cell Research (ISSCR); California Institute for Regenerative Medicine (CIRM);New York Stem Cell Foundation (NYSCF);American association of tissue banks;Tissue Engineering International & Regenerative Medicine Society (TERMIS).

Asia:

Asia Pacific Association of Surgical Tissue Banking;Japanese Society for Regenerative Medicine;Taiwan Society for Stem Cell Research;The New South Wales Stem Cell Network;Korean Society for Stem Cell Research.

Whole Organ Engineering and Approaches

Guided tissue regeneration is defined as procedures attempting to regenerate lost periodontal structures through differential tissue responses. Guided bone regeneration typically refers to ridge augmentation or bone regenerative procedures it typically refers to regeneration of periodontal therapy. The recent advancements and innovations in biomedical and regenerative tissue engineering techniques include the novel approach of guided tissue regeneration.

RelatedRegenerative Medicine Conferences|Stem Cell Conferences|Stem Cell Congress|Tissue Science Conferences|EuropeConferences

Europe:Stem Cell Network North Rhine-Westphalia;German Stem Cell Network (GSCN);German Society for Stem Cell Research (GSZ);Stem Cell Network North Rhine-Westphalia (NRW);Norwegian Center for Stem Cell Research (NCSCR);European Tissue Repair Society;Spanish Association of Tissue Bank.

USA:International Society for Stem Cell Research (ISSCR);Tissue Engineering International & Regenerative Medicine Society (TERMIS);Adult Stem Cell Research Network (ASCR);California Institute for Regenerative Medicine (CIRM);New York Stem Cell Foundation (NYSCF);Regenerative Medicine Foundation.

Asia:

Japanese Society for Regenerative Medicine;Australian Society for Stem Cell Research (ASSCR);The New South Wales Stem Cell Network;Korean Society for Stem Cell Research;Taiwan Society for Stem Cell Research;Stem Cell Society Singapore (SCSS);

Stem Cell Engineering (SCE)

Stem cell engineering (SCE) was to gather information on the worldwide status and trends of research and development in field SCE, that is, the engineers and engineering approaches in the stem cell field, both in basic research and translation of research into clinical applications and commercial products. The study of Stem Cells Engineering is facilitated and managed by the World Technology Evaluation Center (WTEC). This will provide a support for the generation of future economic growth and new markets. The process involved site visits in both Europe and Asia, and it also included several different workshops.

RelatedRegenerative Medicine Conferences|Stem Cell Conferences|Stem Cell Congress|Tissue Science Conferences|EuropeConferences

Modeling Cell-Cell Interactions Governing Tissue Repair & Disease, Gordon Conference, August 19-24, 2018 Waterville Valley, NH, USA;27thInternational Conference On Oncology Research & Cancer Stem CellsMay 10-12, 2018 Frankfurt, Germany;10thAnnual Conference On Stem Cell And Regenerative MedicineAugust 13-14, 2018 London, UK;7thInternational Conference And Exhibition On Cell And Gene TherapyMarch 15-17, 2018London, UK;10thWorld Congress And Expo On Cell & Stem Cell ResearchMarch 19-21, 2018 New York, USA.

Related Associations and Societies:

Europe:Danish Stem Cell Society (DASCS);Stem Cell Network North Rhine-Westphalia;German Society for Stem Cell Research (GSZ);Stem Cell Network North Rhine-Westphalia (NRW);Spanish Association of Tissue Bank;European Calcified Tissue Society;European Association of Tissue Banks.

USA:Adult Stem Cell Research Network (ASCR);California Institute for Regenerative Medicine (CIRM);New York Stem Cell Foundation (NYSCF);Tissue Engineering International & Regenerative Medicine Society (TERMIS);International Society for Stem Cell Research (ISSCR);Regenerative Medicine Foundation.

Asia:

Australian Society for Stem Cell Research (ASSCR);The New South Wales Stem Cell Network;Korean Society for Stem Cell Research;Japanese Society for Regenerative Medicine;Taiwan Society for Stem Cell Research;Stem Cell Society Singapore (SCSS);

Cord Blood Stem Cells and Regenerative Medicine

Recently, cord blood stems cells are developed in the treatment of different diseases, including a broad range of cancers, blood disorders, and genetic diseases. In a cord blood transplant, stem cells are infused in to a patients bloodstream for healing and repairing damaged cells and tissue. In a successful transplant, new healthy immune system has been created. The natural power and purity of newborn's cord blood are responsible for healthy development during gestation. Cord blood applications have developed beyond transplant medicine into the areas of regenerative medicine including brain injuries, autism, Cardiac Problems, and Autoimmune Deficiencies. The latest research in routine transplantation of cord blood are reviewed followed by the critical role of cord blood stem cells in regenerative medicine research and novel approaches using cord blood as a source of whole blood for transfusion.

RelatedRegenerative Medicine Conferences|Stem Cell Conferences|Stem Cell Congress|Tissue Science Conferences|EuropeConferences

11thWorld Congress On Cell & Tissue ScienceMay 14-15, 2018 Tokyo, Japan;11thInternational Conference And Exhibition On Metabolomics & Systems BiologyMay 16-18, 2018 Tokyo, Japan;World Congress On Cell And Structural BiologyMay 28-29, 2018 Osaka, Japan;13thInternational Conference On Metabolomics And Systems BiologyJune 11-12, 2018 London, UK;10thGlobal Summit On Immunology And Cell BiologyMay 28-29, 2018 Osaka, Japan;World Congress On Stem Cell Biology And BiobankingAugust 20-21, 2018 Tokyo, Japan;2ndAnnual Summit On Cell MetabolismSeptember 19 - 20, 2018 Philadelphia, USA.

Related Associations and Societies:

Europe:EuroStemCell (European Consortium for Stem Cell Research);German Stem Cell Network (GSCN);German Society for Stem Cell Research (GSZ);British Association of Tissue Banks;British Association for Tissue Banking;European Tissue Repair Society;Spanish Association of Tissue Bank;European Calcified Tissue Society;European Association of Tissue Banks;

USA:California Institute for Regenerative Medicine (CIRM);New York Stem Cell Foundation (NYSCF);Tissue Engineering International & Regenerative Medicine Society (TERMIS);International Society for Stem Cell Research (ISSCR).

Asia:

The New South Wales Stem Cell Network;Korean Society for Stem Cell Research;Japanese Society for Regenerative Medicine;Taiwan Society for Stem Cell Research;Stem Cell Society Singapore (SCSS).

Bone and Cartilage Tissue Engineering

This interdisciplinary engineering has attracted much attention as a new therapeutic means that may overcome the drawbacks involved in the current artificial organs and organ transplantation that have been also aiming at replacing lost or severely damaged tissues or organs. Tissue engineering and regenerative medicine is an exciting research area that aims at regenerative alternatives to harvested tissues for organ transplantation with soft tissues. Although significant progress has been made in the tissue engineering field, many challenges remain and further development in this area will require on-going interactions and collaborations among the scientists from multiple disciplines, and in partnership with the regulatory and the funding agencies. As a result of the medical and market potential, there is significant academic and corporate interest in this technology.

RelatedRegenerative Medicine Conferences|Stem Cell Conferences|Stem Cell Congress|Tissue Science Conferences|EuropeConferences

2ndAnnual Summit On Cell Signaling And Cancer TherapySeptember 19 - 20, 2018 Philadelphia, USA;2ndAnnual Summit On Cell Therapy And Regenerative MedicineOctober 03-04, 2018 Atlanta, USA;Cellular Therapies2018 San Francisco, USA;4thInternational Conference On Central Nervous System Disorders & TherapeuticsNovember 12-14, 2018 Edinburgh, Scotland

Related Associations and Societies:

Europe:EuroStemCell (European Consortium for Stem Cell Research);German Stem Cell Network (GSCN);German Society for Stem Cell Research (GSZ);Stem Cell Network North Rhine-Westphalia (NRW);Norwegian Center for Stem Cell Research (NCSCR);ScanBalt Stem Cell Research Network;

USA:California Institute for Regenerative Medicine (CIRM);American Association of tissue banks;New York Stem Cell Foundation (NYSCF);Tissue Engineering International & Regenerative Medicine Society (TERMIS);

Asia:Asia Pacific Association of Surgical Tissue Banking;The New South Wales Stem Cell Network;Korean Society for Stem Cell Research;Japanese Society for Regenerative Medicine;Taiwan Society for Stem Cell Research;

Cancer Stem Cells

Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample. CSCs are therefore tumorigenic (tumor-forming), perhaps in contrast to other non-tumorigenic cancer cells. CSCs may generate tumors through the stem cell processes of self-renewal and differentiation into multiple cell types. Such cells are hypothesized to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors. Therefore, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for patients with metastatic disease.

RelatedRegenerative Medicine Conferences|Stem Cell Conferences|Stem Cell Congress|Tissue Science Conferences|EuropeConferences

2ndAnnual Summit On Cell Signaling And Cancer TherapySeptember 19 - 20, 2018 Philadelphia, USA;2ndAnnual Summit On Cell Therapy And Regenerative MedicineOctober 03-04, 2018 Atlanta, USA;Cellular Therapies2018 San Francisco, USA;4thInternational Conference On Central Nervous System Disorders & TherapeuticsNovember 12-14, 2018 Edinburgh, Scotland

Related Associations and Societies:

Europe:EuroStemCell (European Consortium for Stem Cell Research);German Stem Cell Network (GSCN);German Society for Stem Cell Research (GSZ);Stem Cell Network North Rhine-Westphalia (NRW);Norwegian Center for Stem Cell Research (NCSCR);ScanBalt Stem Cell Research Network;

USA:California Institute for Regenerative Medicine (CIRM);American Association of tissue banks;New York Stem Cell Foundation (NYSCF);Tissue Engineering International & Regenerative Medicine Society (TERMIS);

Asia:Asia Pacific Association of Surgical Tissue Banking;The New South Wales Stem Cell Network;Korean Society for Stem Cell Research;Japanese Society for Regenerative Medicine;Taiwan Society for Stem Cell Research;

Market Analysis Report

Tissue Engineeringis an interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function or a whole organ. Regenerative medicine is not one discipline. It can be defined as a therapeutic intervention which replaces or regenerates human cells, tissues or organs, to restore or establish normal function and deploys small molecule drugs, biologics, medical devices and cell-based therapies

Currently, it has emerged as a rapidly diversifying field with the potential to address the worldwide organ shortage issue and comprises of tissue regeneration and organ replacement. Regenerative medicine could potentially save public health bodies money by reducing the need for long-term care and reducing associated disorders, with potential benefits for the world economy as a whole. The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate (CAGR) of 22.3%. On the basis of geography, Europe holds the second place in the global market in the field of regenerative medicine & tissue engineering. In Europe countries like the UK, France and Germany are possessing good market shares in the field of regenerative medicine and tissue engineering. Spain and Italy are the emerging market trends for tissue engineering in Europe.

See the article here:
Regenerative Medicine Conferences | Tissue Science ...

Posted in Regenerative Medicine | Comments Off on Regenerative Medicine Conferences | Tissue Science …

Illinois Stem Cell Clinic – Illinois Stem Cell Clinic …

Posted: October 6, 2018 at 11:41 pm

Umbilical cord cells include stem cells, growth factors and a range of other beneficial proteins and compounds. We use blood from the umbilical cord which has been purified to get rid of any harmful substances that might cause rejection of the treatment by your body. We inject the treated cord blood into the affected area, where the various active compounds found in cord cells go to work immediately to begin inflammation reduction and the promotion of healthy cell division and renewal. Some of the active compounds at work include VEGF (Vascular Endothelial Growth Factor), IL-LRA (Interleukin-1, a receptor antagonist, stem cell factors (SCF), FGF-2 (Fibroblast Growth Factor-2) and Transforming Growth Factor-beta (TGF-beta). Each of these compounds has a slightly different effect, but the net result is that the damaged cells in your joints are given the ingredients they need to kick-start healthy renewal and regeneration. The injection changes the chemistry inside the joint, creating a healthier environment that encourages positive, healing changes to take place. A better blood supply to the area, a reduction in damaging chronic inflammation and stimulation of healthy tissue growth are all typical consequences of the minimally invasive stem cell treatments we provide. By using umbilical cord cells in this way, its possible to transform joint therapy into a holistic healing process that prompts the body to enhance its own regenerative efforts. This results in a natural process of joint health improvement in the weeks or months following the injection.

More here:
Illinois Stem Cell Clinic - Illinois Stem Cell Clinic ...

Posted in Illinois Stem Cells | Comments Off on Illinois Stem Cell Clinic – Illinois Stem Cell Clinic …

Stem Cell Centers – Towson > Stem Cell Centers

Posted: October 6, 2018 at 11:40 pm

Dr. Carle graduated from Duke University School of Medicine in 1986 and did his residency in anesthesiology at the University of Virginia (UVA) in Charlottesville, VA.After finishing his residency in 1990 he stayed on the faculty of UVA, and was instrumental in starting the PAIN MEDICINE FELLOWSHIP program at UVA.In 1994, he decided to enter private practice and was hired by the anesthesiology group at Saint Joseph Medical Center in Towson, MD to start a pain management program at the hospital.

After successfully running the pain program at Saint Joseph Medical Center for many years, he decided to leave the anesthesiology group in 2003 to devote 100% of his time to treating patients in pain.In 2003, he started The Carle Center for Pain Management which is located at 7600 Osler Drive, Suite 205 in Towson, MD.

Always at the leading edge of pain medicine, Dr. Carle introduced and expanded many interventional techniques in the Baltimore area including Spinal Cord Stimulation, Radiofrequency Ablations, MLS laser therapy, and many other Interventional pain medicine techniques.He realized a few years ago that regenerative medicine (i.e. stem cells, PRP, etc.) was going to be a game changer in the treatment of pain in the sense that, after managing patients pain for 30 years, regenerative medicine gives me the ability to actually reverse or cure the cause of pain.

Dr. Carle is very active in the American Society of Interventional Pain Physicians (ASIPP) and has served as president of ASIPP of Maryland.He is also very active in the Maryland State Medical Society (MedChi), serving on several committees including the legislative committee which helps formulate health policy in Maryland.He is currently on the Board of the Baltimore County Medical Society.

Dr. Carle, his wife and two college aged sons enjoy the Chesapeake Bay, trips to the beach, fishing, hiking, and biking in nearby state and national parks.He supports the Chesapeake Bay Foundation to restore the health of the Chesapeake Bay.

Peter is the Patient Care Advocate at the Towson, MD clinic. He grew up in the suburbs north of Baltimore, and graduated from The University of Maryland, College Park with a Business and Economics degree.His professional experience includes over 15 years in insurance and healthcare management. Peter is currently pursuing his Masters degree in Healthcare Management.

What excites Peter the most about being in this wonderful field of Regenerative Medicine, is getting to see first-hand howpatients get significantly betterafter all other conventional methods have not succeeded.

In his spare time Peter enjoys spending time with friends and family, playing sports, and playing guitar.Peter is also a passionate skier and enjoys taking a trip or two out west each winter. Peter also enjoys staying active outside, and loves being on the water or at abeach.

See the original post here:
Stem Cell Centers - Towson > Stem Cell Centers

Posted in Maryland Stem Cells | Comments Off on Stem Cell Centers – Towson > Stem Cell Centers

Stem Cell Therapy in Wichita, Kansas | Joint Pain Relief …

Posted: October 6, 2018 at 11:40 pm

Regenerative Medicine

Regenerative Medicine is the process of healing your existing cellsthat have been damaged by aging, disease or trauma, using cell replacement strategies.This allows your body to repair non-functional cells, tissues, and organs to help restore their normal functions.

Regenerative Medicine generally involves the use of stem cell treatment as a minimally-invasive, non-surgical treatment option for patients with a variety of different medical diagnoses.Some of the most innovative uses for stem cell therapy todayinvolve the therapeutic pain treatment of osteoarthritis in the joints and spine.

Power of Stem Cell Therapy

Through advances in research and technology, our stem cell treatments offer non-invasive methods for alleviating pain and inflammation, and getting patients back to the activities they most enjoy. This non-invasive injection therapy is a great alternative for patients with pain that doesnt currently have a surgical option, or find little to no relief from cortisone shots or physical therapy. Through stem cell therapy, Kansas Regenerative Institute fills thatvoid.

At Kansas Regenerative Institute, we use umbilical cord-blood derived mesenchymal stem cells supplied by willing donors who are pre-screened from reputable hospitals, as well as bone marrow stem cellsand PRP (Platelet-Rich Plasma).

View original post here:
Stem Cell Therapy in Wichita, Kansas | Joint Pain Relief ...

Posted in Kansas Stem Cells | Comments Off on Stem Cell Therapy in Wichita, Kansas | Joint Pain Relief …

Learn more about Stem Cell Therapy in Fort Wayne Indiana …

Posted: October 6, 2018 at 8:46 am

What Type Of Stem Cells Do We Use?

There are 3 types of stem cells. Embryonic, which come from developing embryos, Autologous Stem Cells, which come from us and are hard to cultivate, and Umbilical Stem Cells, which come from the the umbilical cord of newborn babies AFTER they are born. We only use the Umbilical Stem Cells.

Not all stem cells are created equal. Regen Med of Indiana utilizes umbilical cord-derived stem cells. Mesenchymal stem cells from the umbilical cord blood are known to have three very important properties: they help reduce inflammation; modulate the immune system; and secrete factors that helps tissue to regenerate.

Umbilical cord stem cells are less mature than other cells, so the bodys immune system is unable to recognize them as foreign and there has never been a single recorded instance of rejection. Umbilical cord stem cells also proliferate more efficiently than older cells, such as those found in the bone marrow and therefore, they are considered to be more potent.

In scientific terms, they are multipotent stromal (connective tissue) cells that stimulates your body to differentiate them into a variety of cell types, including neurons, cartilage, fat, blood (red, white or platelet blood cells), bone, and muscle. Multipotent means they can develop into multiple types of cells, but divide a limited number of times (a built in safety mechanism). They are messengers that signal your body to activate self-healing and regeneration. The MSCs themselves do not create new tissue or healing, they signal your body to activate a cascade of cellular functions. As we age, we have fewer mesenchymal stem cells, therefore getting a boost of day 0 MSCs may help many conditions. Umbilical Cord Stem Cells contain a small, but significant amount of mesenchymal stem cells that signal self-healing and regeneration.

Originally posted here:
Learn more about Stem Cell Therapy in Fort Wayne Indiana ...

Posted in Indiana Stem Cells | Comments Off on Learn more about Stem Cell Therapy in Fort Wayne Indiana …

Department of Human Genetics | The University of Chicago

Posted: October 6, 2018 at 8:46 am

The Department of Human Genetics is the home within the Division of Biological Sciences for the study of basic principles of genetics and genomics as applied to human disease. We provide broad training in experimental genetics and genomics, statistical and population genetics, bioinformatics, and clinical genetics. A common theme throughout our research is the application of basic genetic principles and strategies to the study of disease mechanism, disease susceptibility, and the genetic architecture of complex traits. Our faculty bridge between basic and clinical research and train students for careers in academia, industry, and medicine.

The Department of Human Genetics has an unwavering commitment to diversity, inclusion, free expression, and open discourse.These values are at the core of our roles as scientists, as teachers, and as citizens of a free society.

Science, including genetics, plays a central role in many crucial issues of our time. We are committed to generating rigorous scientific knowledge, training future scientists, and preparing our students to be well-informed citizens in a democratic society.

More:
Department of Human Genetics | The University of Chicago

Posted in Human Genetics | Comments Off on Department of Human Genetics | The University of Chicago

Human Genetics – medschool.ucla.edu

Posted: October 6, 2018 at 8:46 am

A hub of deep expertise, the Department of Human Genetics helps partners across UCLA interpret data and leverage genomic technology to improve study design and solve medical problems.

We demystify genetic complexities to provide vital insights for a range of clinical and research applications. We strive to improve the care of as many patients as possible by pushing our capabilities, developing novel ways to address unanswered questions.

Your next collaboration is right down the street.

Our enviable proximity to the worlds brightest scientific minds enables both thriving scheduled events and impromptu sidewalk powwows. A casual conversation during your coffee run could lead to your next big publication.

Come find out why innovation lives here.

LEARN MORE

Julian Martinez-Agosto, MD, PhDGenetic sequencing unravels rare disease mysteries; among the first medical centers to use exome sequencing.Learn More

Jingyi "Jessica" Li, PhDStatistics professor honored as a leading woman in STEM at the intersection of statistics and biology.Learn More

Aldons J. Lusis, PhDScientists identify 2 hormones that burn fat faster, prevent and reverse diabetes in mice.Learn More

Daniel Geschwind, MD, PhDAutism, schizophrenia, bipolar disorder share molecular traits, study finds.Learn More

Read this article:
Human Genetics - medschool.ucla.edu

Posted in Human Genetics | Comments Off on Human Genetics – medschool.ucla.edu

Integrative Medicine Clinic in Ashburn, VA

Posted: October 6, 2018 at 8:44 am

Integrative Medical Approach

Integrative medicine places the patient at the center of a holistic approach to medical care. Patient's individual needs, risks, and goals are the main driving forces of any integrative therapy. Physicians practicing integrative medicine emphasize that treatment of every aspect of a person's health is crucial to the success of the healing process:

To request more information, please contact our Ashburn integrative medicine clinic today! Call (703) 327-2434 or contact Virginia Center for Health & Wellness online.

Integrative medicine is a multi-disciplinary approach that combines the scientific advances and a variety of effective therapies to treat disease.

Integrative medicine combines conventional and complementary treatment options to achieve optimal health for the patient. It is based on the research which demonstrates that the human body has an innate healing mechanism. Illness occurs when the regenerative processes in the body are disturbed, and the body can no longer keep itself healthy.

Integrative medicine emphasizes the use of the least invasive treatment options necessary to bring the body to a healthy state.

Integrative medicine physicians focus on health optimization and often combine a variety of methods to optimize their patients' health:

To request more information, please contact our Ashburn integrative medicine clinic today! Call (703) 327-2434 or contact Virginia Center for Health & Wellness online.

Read the rest here:
Integrative Medicine Clinic in Ashburn, VA

Posted in Integrative Medicine | Comments Off on Integrative Medicine Clinic in Ashburn, VA

Page 1,355«..1020..1,3541,3551,3561,357..1,3601,370..»